- Patent Title: Modified EGF protein, production method therefor, and use thereof
-
Application No.: US16757823Application Date: 2018-10-23
-
Publication No.: US11339197B2Publication Date: 2022-05-24
- Inventor: Zungyoon Yang , Eun Joo Nam
- Applicant: PROGEN CO., LTD.
- Applicant Address: KR Seoul
- Assignee: PROGEN CO., LTD.
- Current Assignee: PROGEN CO., LTD.
- Current Assignee Address: KR Seoul
- Agency: Sughrue Mion, PLLC
- Priority: KR10-2017-0137132 20171023,KR10-2017-0137140 20171023,KR10-2018-0125012 20181019
- International Application: PCT/KR2018/012569 WO 20181023
- International Announcement: WO2019/083256 WO 20190502
- Main IPC: C07K14/485
- IPC: C07K14/485 ; A61K8/64 ; A61Q19/00 ; C12P21/02 ; A61K38/00

Abstract:
A modified EGF protein, a production method therefor, and a use thereof are disclosed. The modified EGF protein allows an effective delivery of EGF into the cell and exhibits an enhanced half-life span. A method for producing the modified EGF protein includes culturing conditions where host cell growth phase and protein expression phase employ different temperature conditions. A use of the modified EGF protein is also disclosed.
Public/Granted literature
- US20210188931A1 MODIFIED EGF PROTEIN, PRODUCTION METHOD THEREFOR, AND USE THEREOF Public/Granted day:2021-06-24
Information query